Webinar: Effective IMPD Writing. The Quality Part
Effective IMPD writing, including the quality part is a vital document that contains information about an investigational medicinal product and it is an essential part of the Clinical Trial Application (CTA), which is required by competent authorities in EU.
The purpose of this webinar is to share the best practices in the preparation of IMPD in order to meet the expectations of competent authorities and to learn why effective CMC technical writing is crucial for the development of a high quality IMPD.
You will learn about:
1. Regulatory guidelines for the Investigational Medicinal Product Dossier
2. IMPD structure and content
3. Best practices for the preparation of IMPD
- Best practices in IMPD Quality writing;
- Writing style to produce accurate, concise, and clear technical text.
Who should attend? Professionals from the following fields:
- Product Development
Duration: 40 min.
Speakers: Head of the Central Functions for Regulatory Affairs, Ramunė Rūkienė, MSc, and Medical Writer, Eglė Deimantavičiūtė, MSc, who will share their experience on preparing Quality (CMC) part of the Investigational Medicinal Product Dossier (IMPD) and their advice on effective CMC technical writing.
Ramunė Rūkienė, MSc
Head of Regulatory Affairs Central Operations
Starting Clinical Trials for your product?
Make use of our expertise to smoothly prepare for clinical studies. Explore your options in an informal chat with one of our experts.
Other content that might interest you:
Overview of drug registration in Russia The Russian pharmaceutical industry is expected to exceed two trillion Russian rubles in 2020, representing a roughly 10% growth over the previous year. Pharmaceutical revenues are expected to reach 2.35 trillion Russian rubles...
Affiliate-Based Outsourcing (ABO) model for regulatory affairs works as a replacement or an extension of the company's internal local regulatory resources, which often do not fully fulfil the needs for the effective organization, flexible resources, business...
If you are interested in marketing your medicinal product in the fast-growing pharmaceutical market of the Eurasian Economic Union (EAEU) and if you want to how to apply for market authorization in the EAEU, this blog post is for you. The first part of this article...